Literature DB >> 22740398

Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.

Horng-Shen Chen1, Priyankara Wikramasinghe, Louise Showe, Paul M Lieberman.   

Abstract

Chromatin-organizing factors such as CTCF and cohesins have been implicated in the control of complex viral regulatory programs. We investigated the role of CTCF and cohesins in the control of the switch from latency to the lytic cycle for Kaposi's sarcoma-associated herpesvirus (KSHV). We found that cohesin subunits but not CTCF are required for the repression of KSHV immediate early gene transcription. Depletion of the cohesin subunits Rad21, SMC1, and SMC3 resulted in lytic cycle gene transcription and viral DNA replication. In contrast, depletion of CTCF failed to induce lytic transcription or DNA replication. Chromatin immunoprecipitation with high-throughput sequencing (ChIP-Seq) revealed that cohesins and CTCF bound to several sites within the immediate early control region for ORF50 and to more distal 5' sites that also regulate the divergently transcribed ORF45-ORF46-ORF47 gene cluster. Rad21 depletion led to a robust increase in ORF45, ORF46, ORF47, and ORF50 transcripts, with similar kinetics to that observed with chemical induction by sodium butyrate. During latency, the chromatin between the ORF45 and ORF50 transcription start sites was enriched in histone H3K4me3, with elevated H3K9ac at the ORF45 promoter and elevated H3K27me3 at the ORF50 promoter. A paused form of RNA polymerase II (Pol II) was loosely associated with the ORF45 promoter region during latency but was converted to an active elongating form upon reactivation induced by Rad21 depletion. Butyrate treatment caused a rapid dissociation of cohesins and loss of CTCF binding at the immediate early gene locus, suggesting that cohesins may be a direct target of butyrate-mediated lytic induction. Our findings implicate cohesins as a major repressor of KSHV lytic gene activation and show that they function coordinately with CTCF to regulate the switch between latent and lytic gene activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740398      PMCID: PMC3416178          DOI: 10.1128/JVI.00787-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.

Authors:  S Zhou; S D Hayward
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.

Authors:  Yi Jin; Zhiheng He; Deguang Liang; Quanzhi Zhang; Hongxing Zhang; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.

Authors:  S Sakakibara; K Ueda; J Chen; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  Shie-Shan Wang; Pey-Jium Chang; Lee-Wen Chen; Li-Yu Chen; Chien-Hui Hung; Jieh-Yuan Liou; Ju-Bei Yen
Journal:  Virus Res       Date:  2012-02-18       Impact factor: 3.303

5.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Fang Lu; Kevin Tsai; Horng-Shen Chen; Priyankara Wikramasinghe; Ramana V Davuluri; Louise Showe; John Domsic; Ronen Marmorstein; Paul M Lieberman
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

8.  A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.

Authors:  Fan Xiu Zhu; Sonya M King; Eric J Smith; David E Levy; Yan Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

9.  Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication.

Authors:  Zhong Deng; Larissa Lezina; Chi-Ju Chen; Svetlana Shtivelband; Wingkan So; Paul M Lieberman
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

10.  CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Yanxing Yu; Gary S Hayward
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more
  55 in total

1.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

2.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

3.  Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Jason M Schifano; Kathleen Corcoran; Hemant Kelkar; Dirk P Dittmer
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 4.  Emerging Proviral Roles of Caspases during Lytic Replication of Gammaherpesviruses.

Authors:  Tate Tabtieng; Marta M Gaglia
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Xiaolan Yu; Abdel-Malek Shahir; Jingfeng Sha; Zhimin Feng; Betty Eapen; Stanley Nithianantham; Biswajit Das; Jonathan Karn; Aaron Weinberg; Nabil F Bissada; Fengchun Ye
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Activation and degradation of open reading frame 45 by the replication and transcription activator of Kaposi's sarcoma-associated herpesvirus.

Authors:  Ying Wang; Kai Yu; Xiuzhi Pei; Tianzheng Zhang; Yuying Guo; Charles Wood; Jinzhong Wang
Journal:  J Gen Virol       Date:  2015-03-17       Impact factor: 3.891

7.  Cohesin subunit Rad21 binds to the HSV-1 genome near CTCF insulator sites during latency in vivo.

Authors:  Pankaj Singh; Donna M Neumann
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

8.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 9.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

Review 10.  Snapshots: chromatin control of viral infection.

Authors:  David M Knipe; Paul M Lieberman; Jae U Jung; Alison A McBride; Kevin V Morris; Melanie Ott; David Margolis; Amelia Nieto; Michael Nevels; Robin J Parks; Thomas M Kristie
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.